Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Glauser

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|November 11, 1982
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coliE J Ziegler, J A McCutchan, J Fierer, et al.
The American Journal of Gastroenterology|December 1, 1994
Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptomsJ P Chave, J Thorens, F Fröhlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14D Le Roy, F Di Padova, R Tees, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 22, 2002
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patientsM P Glauser, U Brennscheidt, O Cornely, et al.
Infection and Immunity|February 1, 1997
Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in miceS Bailat, D Heumann, D Le Roy, et al.
Genitourinary Medicine|April 1, 1996
Epidemiology of cryptosporidiosis among European AIDS patientsC Pedersen, S Danner, A Lazzarin, et al.
Journal of Inflammation|January 1, 1995
Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitisD Heumann, D Le Roy, G Zanetti, et al.
Infection and Immunity|February 1, 1993
Purification and characterization of murine lipopolysaccharide-binding proteinP Gallay, S Carrel, M P Glauser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytesD Heumann, P Gallay, C Barras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharideG Zanetti, D Heumann, J Gérain, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|November 11, 1982
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coliE J Ziegler, J A McCutchan, J Fierer, et al.
The American Journal of Gastroenterology|December 1, 1994
Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptomsJ P Chave, J Thorens, F Fröhlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14D Le Roy, F Di Padova, R Tees, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 22, 2002
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patientsM P Glauser, U Brennscheidt, O Cornely, et al.
Infection and Immunity|February 1, 1997
Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in miceS Bailat, D Heumann, D Le Roy, et al.
Genitourinary Medicine|April 1, 1996
Epidemiology of cryptosporidiosis among European AIDS patientsC Pedersen, S Danner, A Lazzarin, et al.
Journal of Inflammation|January 1, 1995
Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitisD Heumann, D Le Roy, G Zanetti, et al.
Infection and Immunity|February 1, 1993
Purification and characterization of murine lipopolysaccharide-binding proteinP Gallay, S Carrel, M P Glauser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytesD Heumann, P Gallay, C Barras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharideG Zanetti, D Heumann, J Gérain, et al.
Pageof 25